Airain Ltd’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
Sell
-9,663
Closed -$408K 1232
2015
Q2
$408K Buy
+9,663
New +$408K 0.02% 570
2014
Q4
Sell
-13,249
Closed -$464K 1057
2014
Q3
$464K Sell
13,249
-8,669
-40% -$297K 0.03% 467
2014
Q2
$720K Sell
21,918
-13,055
-37% -$447K 0.06% 337
2014
Q1
$1.29M Buy
+34,973
New +$1.28M 0.23% 144

Other funds holding WX

Airain Ltd's WX Position: Q3 2015 in Review

Airain Ltd sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q3 2015, closing a stake of 9,663 shares — an estimated $408K sold.

Airain Ltd first reported a position in WX in Q1 2014 and held it in 4 quarters. The position peaked at $1.29M in Q1 2014. 151 funds tracked by Wall St. Rank hold WX as of Q3 2015.

  • Airain Ltd reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q3 2015 after selling out during the quarter.
  • Airain Ltd sold 9,663 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q3 2015, an estimated $408K.
  • Airain Ltd first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q1 2014 and held it in 4 quarters.
  • Airain Ltd's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $1.29M in Q1 2014.
  • 151 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q3 2015.

Based on Airain Ltd's 13F filing for Q3 2015, filed 9 Nov 2015.